Conference
A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease
Authors
Kishnani P; Tarnopolsky M; Sivakumar K; Roberts M; Byrne B; Goker-Alpan O; Guter K; Pervaiz MA; Dasouki M; Mozaffar T
Volume
108
Publisher
Elsevier
Publication Date
February 2013
DOI
10.1016/j.ymgme.2012.11.131
Conference proceedings
Molecular Genetics and Metabolism
Issue
2
ISSN
1096-7192